[HTML][HTML] Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application
R Huang, Z Chen, L He, N He, Z Xi, Z Li, Y Deng… - Theranostics, 2017 - ncbi.nlm.nih.gov
There is a critical need for the discovery of novel biomarkers for early detection and targeted
therapy of cancer, a major cause of deaths worldwide. In this respect, proteomic …
therapy of cancer, a major cause of deaths worldwide. In this respect, proteomic …
Overall and stage-specific survival of patients with screen-detected colorectal cancer in European countries: A population-based study in 9 countries
Background An increasing proportion of colorectal cancers (CRCs) are detected through
screening due to the availability of organised population-based programmes. We aimed to …
screening due to the availability of organised population-based programmes. We aimed to …
Long-term evaluation of benefits, harms, and cost-effectiveness of the National Bowel Cancer Screening Program in Australia: a modelling study
JB Lew, DJB St John, XM Xu, MJE Greuter… - The Lancet Public …, 2017 - thelancet.com
Background No assessment of the National Bowel Screening Program (NBCSP) in
Australia, which considers all downstream benefits, costs, and harms, has been done. We …
Australia, which considers all downstream benefits, costs, and harms, has been done. We …
[HTML][HTML] Faecal immunochemical test outside colorectal cancer screening?
N Pin-Vieito, M Puga… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Faecal immunochemical tests (FITs) are the most widely colorectal cancer (CRC) diagnostic
biomarker available. Many population screening programmes are based on this biomarker …
biomarker available. Many population screening programmes are based on this biomarker …
[HTML][HTML] Effectiveness of colorectal cancer screening in detecting earlier-stage disease—a nationwide cohort study in Denmark
MB Larsen, S Njor, P Ingeholm, B Andersen - Gastroenterology, 2018 - Elsevier
Background & Aims Most studies of the effectiveness of screening for colorectal cancer
(CRC) using the fecal occult blood test tested the guaiac fecal occult blood test. However …
(CRC) using the fecal occult blood test tested the guaiac fecal occult blood test. However …
[HTML][HTML] Survival of patients with symptom-and screening-detected colorectal cancer
H Brenner, L Jansen, A Ulrich, J Chang-Claude… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Background An increasing proportion of colorectal cancer (CRC) patients are diagnosed by
screening rather than symptoms. Aims We aimed to assess and compare prognosis of …
screening rather than symptoms. Aims We aimed to assess and compare prognosis of …
Consequences of increasing time to colonoscopy examination after positive result from fecal colorectal cancer screening test
RGS Meester, AG Zauber, CA Doubeni… - Clinical …, 2016 - Elsevier
Background & Aims Delays in diagnostic testing after a positive result from a screening test
can undermine the benefits of colorectal cancer (CRC) screening, but there are few …
can undermine the benefits of colorectal cancer (CRC) screening, but there are few …
Evaluation of the benefits, harms and cost‐effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia
JB Lew, DJB St. John, FA Macrae… - … journal of cancer, 2018 - Wiley Online Library
The Australian National Bowel Cancer Screening Program (NBCSP) will fully roll‐out 2‐
yearly screening using the immunochemical Faecal Occult Blood Testing (iFOBT) in people …
yearly screening using the immunochemical Faecal Occult Blood Testing (iFOBT) in people …
Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model
I Idigoras, A Arrospide, I Portillo, E Arana-Arri… - BMC Public Health, 2018 - Springer
Abstract The population-based Basque Colorectal Cancer (CRC) Screening Programme
started in 2009 with a biennial immunochemical quantitative test (FIT) biennial and …
started in 2009 with a biennial immunochemical quantitative test (FIT) biennial and …
Benefits, harms, and cost-effectiveness of potential age extensions to the national bowel cancer screening program in Australia
Abstract Background: The Australian National Bowel Cancer Screening Program (NBCSP)
is rolling out 2-yearly immunochemical fecal occult blood test screening in people aged 50 …
is rolling out 2-yearly immunochemical fecal occult blood test screening in people aged 50 …